AbbVie Inc. (ABBV): Price and Financial Metrics

ABBV POWR Grades

• Value is the dimension where ABBV ranks best; there it ranks ahead of 92.76% of US stocks.
• ABBV's strongest trending metric is Growth; it's been moving up over the last 52 weeks.
• ABBV ranks lowest in Momentum; there it ranks in the 16th percentile.

ABBV Stock Summary

• ABBV has a market capitalization of $193,488,048,999 -- more than approximately 98.89% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 10.96 for AbbVie Inc; that's greater than it is for 93.33% of US stocks.
• In terms of volatility of its share price, ABBV is more volatile than only 3.42% of stocks we're observing.
• Stocks with similar financial metrics, market capitalization, and price volatility to AbbVie Inc are NVS, AZN, TXN, SAP, and CSCO.
• Visit ABBV's SEC page to see the company's official filings. To visit the company's web site, go to www.abbvie.com.

ABBV Valuation Summary

• ABBV's EV/EBIT ratio is 33.9; this is 15.7% higher than that of the median Healthcare stock.
• ABBV's EV/EBIT ratio has moved up 18.8 over the prior 105 months.
• ABBV's price/earnings ratio has moved up 15.8 over the prior 105 months.

Below are key valuation metrics over time for ABBV.

ABBV Growth Metrics

• Its year over year price growth rate is now at 37.86%.
• The 2 year price growth rate now stands at -16.18%.
• The year over year net income to common stockholders growth rate now stands at -38.85%.

ABBV's revenue has moved up $27,019,000,000 over the prior 49 months.

The table below shows ABBV's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	53,729	20,451	6,663
2021-03-31	50,195	18,650	5,159
2020-12-31	45,804	17,588	4,616
2020-09-30	40,650	16,009	7,381
2020-06-30	36,227	14,734	6,957
2020-03-31	34,057	14,122	8,436

ABBV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ABBV has a Quality Grade of B, ranking ahead of 76.93% of graded US stocks.
• ABBV's asset turnover comes in at 0.359 -- ranking 133rd of 680 Pharmaceutical Products stocks.
• CAPR, HSTO, and BCDA are the stocks whose asset turnover ratios are most correlated with ABBV.

The table below shows ABBV's key quality metrics over time.